ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,912,393 | -22.6% | 457,654 | +0.4% | 0.02% | -20.8% |
| Q2 2022 | $12,804,360 | +4.0% | 455,684 | +70.8% | 0.02% | +41.2% |
| Q1 2022 | $12,309,753 | +9.8% | 266,786 | +100.0% | 0.02% | -41.4% |
| Q4 2021 | $11,213,000 | +27.7% | 133,392 | +1.2% | 0.03% | +16.0% |
| Q3 2021 | $8,783,000 | -35.0% | 131,801 | -48.1% | 0.02% | +31.6% |
| Q2 2021 | $13,506,000 | +89.8% | 253,890 | +54.8% | 0.02% | -13.6% |
| Q1 2021 | $7,116,000 | -14.9% | 164,012 | +1.9% | 0.02% | -15.4% |
| Q4 2020 | $8,361,000 | +63.9% | 160,970 | +3.1% | 0.03% | +44.4% |
| Q3 2020 | $5,102,000 | -50.2% | 156,087 | -26.8% | 0.02% | -10.0% |
| Q2 2020 | $10,242,000 | – | 213,286 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |